CD26: A negative selection marker for human Treg cells

Cytometry Part A

Volumn 81 A, Issue 10, 2012, Pages 843-855

  Salgado, Francisco J ^a   Pérez Díaz, Amparo ^a   Villanueva, Nora M ^a   Lamas, Olaya ^a   Arias, Pilar ^a   Nogueira, Montserrat ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

CD26; Effector T cells; Flow cytometry; Magnetic sorting; Regulatory T cells

Indexed keywords

BIOLOGICAL MARKER; DIPEPTIDYL PEPTIDASE IV; EPITOPE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA;

ARTICLE; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; REGULATORY T LYMPHOCYTE;

BIOLOGICAL MARKERS; DIPEPTIDYL PEPTIDASE 4; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; T-LYMPHOCYTES, REGULATORY;

EID: 84866620317     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22117     Document Type: Article

References (61)

1. + regulatory T cells. Cell Mol Immunol 2008; 5: 401-406.
2. + regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
3. + regulatory T cells: Differentiation, specification, subphenotypes. Nat Immunol 2009; 10: 689-695.
4. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212: 8-27.
5. + regulatory T cells in transplantation. Am J Transplant 2009; 9: 1719-1724.
6. Joosten SA, Ottenhoff TH. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum Immunol 2008; 69: 760-770.
7. + regulatory T cells: More of the same or a division of labor?. Immunity 2009; 30: 626-635.
8. Corthay A. How do regulatory cells work?. Scand J Immunol 2009; 70: 326-336.
9. + regulatory T-cell-mediated suppression. Immunology 2006; 118: 240-249.
10. Tang Q, Bluestone JA. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006; 212: 217-237.
11. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer 2010; 127: 759-767.
12. high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
13. Aerts NE, Dombrecht EJ, Ebo DG, Bridts CH, Stevens WJ, De Clerck LS. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis. Cell Immunol 2008; 251: 109-115.
14. Jourdan P, Vendrell JP, Huguet MF, Segondy M, Bousquet J, Pène J, Yssel H. Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J Immunol 2000; 165; 716-724.
15. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001; 193: 1303-1310.
16. - T cells by T cell receptor stimulation is TGFβ-dependent but does not confer a regulatory phenotype. Blood 2007; 110: 2983-2890.
17. + T reg cells. J Exp Med 2006; 203: 1701-1711.
18. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between regulatory and activated T cells. J Exp Med 2006; 203: 1693-1700.
19. Del Pozo-Balado M del M, Leal M, Méndez-Lagares G, Pacheco YM. CD4(+)CD25(+/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. J Infect Dis 2010; 201: 331-335.
20. Alves NL, van Leeuwen EM, Derks IA, van Lier RA. Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling. J Immunol 2008; 180: 5201-5210.
21. + Treg free of contaminating effector cells. Blood 2009; 113: 827-836.
22. + Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225-1232.
23. + CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008; 123: 79-89.
24. Mandapathil M, Lang S, Gorelik E, Whiteside TL. Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression. J Immunol Methods 2009; 346: 55-63.
25. Alam MS, Kurtz CC, Rowlett RM, Reuter BK, Wiznerowicz E, Das S, Linden J, Crowe SE, Ernst PB. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 2009; 199: 494-504.
26. Moncrieffe H, Nistala K, Kamhieh Y, Evans J, Eddaoudi A, Eaton S, Wedderburn LR. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J Immunol 2010; 185: 134-143.
27. Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell based tolerogenic therapy?. Nat Rev Immunol 2007; 7: 650-654.
28. Ohnuma K, Dang NH, Morimoto C. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol 2008; 29: 295-301.
29. Cordero OJ, Salgado FJ, Viñuela JE, Nogueira M. Interleukin-12 enhances CD26 expression and Dipeptidyl peptidase IV function on human activated lymphocytes. Immunobiology 1997; 197: 522-533.
30. Hühn J, Ehrlich S, Fleischer B, von Bonin A. Molecular analysis of CD26-mediated signal transduction in T cells. Immunol Lett 2000; 72: 127-132.
31. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol 1991; 147: 2514-2517.
32. Salgado FJ, Lojo J, Fernández-Alonso CM, Alonso-Lebrero JL, Lluis C, Franco R, Viñuela JE, Cordero OJ, Nogueira M. A role for IL-12 in the regulation of T cell plasma membrane compartmentation. J Biol Chem 2003; 278: 24849-24857.
33. Ohnuma K, Uchiyama M, Yamochi T, Nishibashi K, Hosono O, Takahashi N, Kina S, Tanaka H, Lin X, Dang NH, et al. Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1. J Biol Chem 2007; 282: 10117-10131.
34. Canda-Sánchez A, Salgado FJ, Pérez-Díaz A, Varela-González C, Arias P, Nogueira M. IL-12-dependent activation of ERK1/2 in human T lymphoblasts. Immunobiology 2009; 214: 187-196.
35. Hoffmann P, Boeld TJ, Eder R, Huehn J, Floess S, Wieczorek G, Olek S, Dietmaier W, Andreesen R, Edinger M. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009; 39: 1088-1097.
36. Earle KE, Tang Q, Zhou X, Liu W, Zhu S, Bonyhadi ML, Bluestone JA. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 2005; 115: 3-9.
37. Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, Andreesen R, Edinger M. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260-4267.
38. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 2009; 30: 656-665.
39. Molinero LL, Yang J, Gajewski T, Abraham C, Farrar MA, Alegre ML. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol 2009; 182: 6736-6743.
40. Ohnuma K, Ishii T, Iwata S, Hosono O, Kawasaki H, Uchiyama M, Tanaka H, Yamochi T, Dang NH, Morimoto C. G1/S cell cycle arrest provoked in human T cells by antibody to CD26. Immunology 2002; 107: 325-333.
41. + T cells. Biochem Biophys Res Commun 2009; 386: 327-332.
42. Busso N, Wagtmann N, Herling C, Chobaz-Péclat V, Bischof-Delaloye A, So A, Grouzmann E. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 2005; 166: 433-442.
43. Preller V, Gerber A, Wrenger S, Togni M, Marguet D, Tadje J, Lendeckel U, Röcken C, Faust J, Neubert K, et al. TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26. J Immunol 2007; 178: 4632-4640.
44. Steinbrecher A, Reinhold D, Quigley L, Gado A, Tresser N, Izikson L, Born I, Faust J, Neubert K, Martin R, et al. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 2001; 166: 2041-2048.
45. Matteucci E, Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem 2009; 16: 2943-2951.
46. + T cells in a novel F344 rat model of asthma. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1564-1571.
47. + T cells in rats. Int Immunol 2004; 16, 365-375.
48. - T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile. Lab Invest 2008; 88: 482-490.
49. Bengsch B, Seigel B, Flecken T, Wolanski J, Blum HE, Thimme R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). J Immunol 2012; 188: 5438-5447.
50. Simonetta F, Chiali A, Cordier C, Urrutia A, Girault I, Bloquet S, Tanchot C, Bourgeois C. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells. Eur J Immunol 2010; 40: 2528-2538.
51. Cordero OJ, Salgado FJ, Nogueira M. On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother 2009; 58: 1723-1747.
52. + T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009; 106: 1903-1908.
53. Kmieciak M, Gowda M, Graham L, Godder K, Bear HD, Marincola FM, Manjili MH. Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Trans Med 2009; 7: 89.
54. Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, Colle JH, Urrutia A, Scott-Algara D, Boufassa F, et al. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: An ANRS EP36 study. J Virol 2007; 81: 13904-13915.
55. Santner-Nanan B, Seddiki N, Zhu E, Quent V, Kelleher A, Fazekas de St Groth B, Nanan R. Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype. Int Immunol 2008; 20: 375-383.
56. Pacheco R, Martinez-Navio JM, Lejeune M, Climent N, Oliva H, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci USA 2005; 102: 9583-9588.
57. Cordero OJ, Salgado FJ, Fernández-Alonso CM, Herrera C, Lluis C, Franco R, Nogueira M. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes. J Leukoc Biol 2001; 70: 920-930.
58. Ohnuma K, Yamochi T, Uchiyama M, Nishibashi K, Yoshikawa N, Shimizu N, Iwata S, Tanaka H, Dang NH, Morimoto C. CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc Natl Acad Sci USA 2004; 101: 14186-14191.
59. Larsen CP, Ritchie, SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152: 5208-5219.
60. Rudy W, Gückel B, Siebels M, Lindauer M, Meuer SC, Moebious U. Differential function of CD80- and CD86-transfected human melanoma cells in the presence of IL-12 and IFN-γ. Int Immunol 1997; 9: 853-860.
61. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 2004; 172: 2778-2784.